Debiopharm competitive analysis

Latest publications and patents of Debiopharm New

Explore the latest publications and patents granted to Debiopharm, showcasing their recent innovations and technological advancements.

Last updated on: Sep 27, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Debiopharm

Feb 19, 2025Slow Release Pharmaceutical Composition Made Of MicroparticlesPatent Maintained As Amended
Oct 25, 2023Combination Anti Cancer Therapy With An Iap Antagonist And An Anti Pd-1 MoleculeGranted And Under Opposition

Explore Debiopharm's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
Feb 19, 2025Slow Release Pharmaceutical Composition Made Of Microparticles1
Oct 25, 2023Combination Anti Cancer Therapy With An Iap Antagonist And An Anti Pd-1 Molecule1

Latest PTAB cases involving Debiopharm

Discover the latest PTAB cases involving Debiopharm, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Debiopharm with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
DEBIOPHARM - 2 - - Non-Active
GENERICS UK212 - - - Highly Aggressive
KRAUS & LEDERER PARTGMBB67 - - - Highly Aggressive